Every coffee keeps the site running. Thank you!
Tech, gaming and the news that matters
The rapid adoption of GLP-1 weight-loss and diabetes treatments has altered pharmaceutical capital allocation, triggering supply chain investments and new clinical combinations across cardiovascular and metabolic health sectors.
Manufacturing Scale-Up and Market Dynamics
Contract manufacturing organizations are committing billions to fill-finish capacity to meet sustained global demand. Supply constraints are anticipated to persist through late 2025.
Machine learning integration in drug discovery reduces lead optimization timelines across oncology pipelines.
Pharmaceutical giants allocate billions to specialized fill-finish infrastructure to resolve persistent global GLP-1 shortages.
Liposuction is the commonest aesthetic procedure performed in India and is used to cure your body fat. A…
Pharmaceutical supply chains expand manufacturing capacity as metabolic treatments see unprecedented demand across global markets.
Digital health providers move beyond episodic care models to capture recurring enterprise healthcare revenue.
Clinical trial expansions into cardiovascular and metabolic conditions spark revaluations across healthcare and consumer staple industries.